Facebook Linkedin RSS Twitter Youtube
Home 2024

Immunology

Lymphoma Immunotherapy Enhanced by Enzyme Inhibitor In Preclinical Model, Prompting Pilot Clinical Studies
Cancer

Lymphoma Immunotherapy Enhanced by Enzyme Inhibitor In Preclinical Model, Prompting Pilot Clinical Studies

Killer T Cells Programmed for Tissue- and Tumor-Specific Targeting
Cancer

Killer T Cells Programmed for Tissue- and Tumor-Specific Targeting

StockWatch: ARK Mostly Bullish on CRISPR Therapeutics
GEN Edge

StockWatch: ARK Mostly Bullish on CRISPR Therapeutics

Locally Immunoprotective Synthetic Suppressor T Cells Could Reduce Need for Systemic Immunosuppression
Featured

Locally Immunoprotective Synthetic Suppressor T Cells Could Reduce Need for Systemic Immunosuppression

Label-Free HILIC-MS Counts and IDs Subunit Free Thiol in mAbs
Bioprocessing

Label-Free HILIC-MS Counts and IDs Subunit Free Thiol in mAbs

Multiple Factors Influence Host Cell Protein Levels
Bioprocessing

Multiple Factors Influence Host Cell Protein Levels

Force of Nature: Enveda Raises $130M, Advances Lead Pipeline Candidate
Artificial Intelligence

Force of Nature: Enveda Raises $130M, Advances Lead Pipeline Candidate

Cancer Immunotherapy Could Turn Up the Heat on Cold Tumors by Suppressing UBA1
Cancer

Cancer Immunotherapy Could Turn Up the Heat on Cold Tumors by Suppressing UBA1

CAR T Cells Armed with IL-15 Show Promise in Solid Cancer Therapy
Cancer

CAR T Cells Armed with IL-15 Show Promise in Solid Cancer Therapy

Targeting “Proteolethargy” to Restore Protein Mobility May Represent Therapeutic Approach for Chronic Diseases
Featured

Targeting “Proteolethargy” to Restore Protein Mobility May Represent Therapeutic Approach for Chronic Diseases

123...582Page 1 of 582
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.